Work

PKC412 Is a Multi-Targeting Kinase Inhibitor with Activity Against Multiple Myeloma In Vitro and In Vivo.

Year: 2005

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood.v106.11.247.247

Authors: Joseph Negri, Nicholas Mitsiades, Qingwei Deng, Zhaoqin Wen, David C. Geer, Ciaran McMullan, Vassiliki Poulaki, Teru Hideshima, Dharminder Chauhan, Thomas Meyer, Nikhil C. Munshi, Paul G. Richardson, Andrew L. Kung, Kenneth C. Anderson, Constantine S. Mitsiades

Institutions: Harvard University, Dana-Farber Cancer Institute, Novartis (Switzerland), Novartis Institutes for BioMedical Research

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2992595130

Cites:

Cited by: 3

Related to: 10